MATSUI CONNIE — SEC Form 4 filings
SEC reporting owner CIK 1236537. 13 Form 4 filings on record with FilingPulse; latest filed 2026-07-21.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-03-01 to 2026-07-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 50,000 shares, $39,950 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 27.
- Largest priced transaction: purchase of 50,000 shares @ $0.80 ($39,950) in SUTRO BIOPHARMA, INC., filed 2025-10-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| SUTRO BIOPHARMA, INC. (STRO) | Director | 5 | 1 leg · 50,000 sh · $39,950 | — | 4 |
| ARTELO BIOSCIENCES, INC. (ARTL) | Director | 6 | — | — | 20 |
| HALOZYME THERAPEUTICS, INC. (HALO) | Director | 2 | — | — | 3 |
Form 4 filings — MATSUI CONNIE
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-21 | 4 | ARTELO BIOSCIENCES, INC. (ARTL) | Grant/award (A): 136 (derivative) @ $0 | EDGAR |
| 2026-06-09 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | ARTELO BIOSCIENCES, INC. (ARTL) | Grant/award (A): 292 (derivative) @ $0 | EDGAR |
| 2025-12-29 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Grant/award (A): 1,500 (derivative) @ $0 | EDGAR |
| 2025-10-30 | 4 | ARTELO BIOSCIENCES, INC. (ARTL) | Conversion (C) @ $140,000 · Conversion (C): 38,346 (derivative) · Conversion (C): 70,376 (derivative) · Conversion (C) @ $110,843 | EDGAR |
| 2025-10-16 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Purchase (P): 50,000 @ $0.80 | EDGAR |
| 2025-06-10 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-05 | 4 | ARTELO BIOSCIENCES, INC. (ARTL) | Purchase (P) @ $140,000 | EDGAR |
| 2024-12-23 | 4 | ARTELO BIOSCIENCES, INC. (ARTL) | Grant/award (A): 1,750 (derivative) @ $0 | EDGAR |
| 2024-12-03 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Gift (G): 10,470 @ $0 | EDGAR |
| 2024-06-10 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2024-04-29 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Grant/award (A): 6,501 @ $0 · Grant/award (A): 8,804 (derivative) @ $0 | EDGAR |
| 2024-03-01 | 4 | ARTELO BIOSCIENCES, INC. (ARTL) | Disposition to issuer (D): 1,767 (derivative) · Disposition to issuer (D): 10,634 (derivative) · Disposition to issuer (D): 667 (derivative) · Disposition to issuer (D): 667 (derivative) · Disposition to issuer (D): 667 (derivative) · Disposition to issuer (D): 1,083 (derivative) · +6 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1236537 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →